Aesthetic Medical International (AIH)
(Delayed Data from NSDQ)
$0.41 USD
+0.01 (3.72%)
Updated Apr 18, 2024 03:57 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Aesthetic Medical International Hldngs Group Ltd Sponsored ADR falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | NA | 100 | 100 | 131 | 126 |
Cost Of Goods | NA | 47 | 58 | 52 | 40 |
Gross Profit | NA | 53 | 42 | 79 | 86 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 60 | 94 | 107 | 86 |
Income After Depreciation & Amortization | 0 | -7 | -52 | -29 | 0 |
Non-Operating Income | NA | -4 | -49 | -5 | 25 |
Interest Expense | NA | 3 | 4 | 4 | 4 |
Pretax Income | NA | -14 | -106 | -38 | 22 |
Income Taxes | NA | -3 | -2 | -2 | 2 |
Minority Interest | NA | 0 | -13 | -2 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | -11 | -104 | -36 | 20 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | -11 | -91 | -34 | 20 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 2 | -37 | -13 | 12 |
Depreciation & Amortization (Cash Flow) | NA | 9 | 15 | 15 | 12 |
Income After Depreciation & Amortization | 0 | -7 | -52 | -29 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | NA | 27.30 | 21.92 | 21.87 | 15.18 |
Diluted EPS Before Non-Recurring Items | NA | -0.06 | -1.89 | -0.70 | -1.42 |
Diluted Net EPS (GAAP) | NA | -0.42 | -4.13 | -1.57 | -0.34 |
Fiscal Year end for Aesthetic Medical International Hldngs Group Ltd Sponsored ADR falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | 44.03 | 21.68 |
Cost Of Goods | NA | NA | NA | 23.11 | 11.10 |
Gross Profit | NA | NA | NA | 20.93 | 10.58 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 22.58 | 10.31 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | -1.65 | 0.27 |
Non-Operating Income | NA | NA | NA | 0.00 | 0.00 |
Interest Expense | NA | NA | NA | 1.33 | 0.77 |
Pretax Income | NA | NA | NA | -2.96 | -0.50 |
Income Taxes | NA | NA | NA | -1.40 | -0.52 |
Minority Interest | NA | NA | NA | -0.18 | -0.04 |
Investment Gains/Losses | NA | NA | NA | 0.00 | 0.00 |
Other Income/Charges | NA | NA | NA | 0.00 | 0.00 |
Income From Cont. Operations | NA | NA | NA | -1.57 | 0.03 |
Extras & Discontinued Operations | NA | NA | NA | 0.00 | 0.00 |
Net Income (GAAP) | NA | NA | NA | -1.39 | 0.07 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | 45.91 | 38.89 |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | -0.03 | 0.01 |
Diluted Net EPS (GAAP) | NA | NA | NA | -0.03 | 0.00 |